Canadian Collaborative Research Network
Avatar

What Every GP Should Know About Heart Failure in 2024?

By Canadian Collaborative Research Network FEATURING Stephanie Poon
By Canadian Collaborative Research Network FEATURING Stephanie Poon
1,107 views
August 13, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

02:17
Novartis Cardiology

Understanding Acquisition and Billing for a Non-Statin Lipid-Lowerin…

Feat. B. Buell

Featured Video

05:11
Novartis Cardiology

Initiating and Monitoring Patients on a Non-Statin Lipid-Lowering Th…

Feat. R. Sugumaran, P. Shah, S. Shugg

Related Content

AUTOPLAY
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
11:37
ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich
11:25
ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster
27:14
MUSC Cardiology

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

Feat. R. Mentz
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo
17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

27:24
Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan
61:49
Obafemi Awolowo University

Management of Heart Failure

Feat. O. A. Akinyele
09:52
AHA 2022 Conference Coverage

AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…

Feat. R. Mentz
13:07
Michelle Kittleson

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

35:16
Scripps Health

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Feat. M. Kittleson
17:14
Craig Beavers

Managing Iron Deficiency in Heart Failure: Recognizing the Need for …

12:12
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT in NYHA Class II…

Feat. W. Abraham
28:48
MUSC Cardiology

Weight Loss as Treatment for HFpEF: An Update on Drugs and Procedures

Feat. S. Litwin
11:29
The 9th Annual Western New England Acute Cardiology Conference

Esmolol in Refractory VF

Feat. B. Hoffman
19:30
ACC 2022 Conference Coverage

Hot Topics in Heart Failure ACC.22

Feat. N. Ibrahim
12:30
Houston Methodist Hospital

Amyloidosis Types and Pathophysiology

Feat. B. Trachtenberg
17:29
UCLA Health

Cardiac Amyloidosis: A New Era of Diagnostics and Therapeutics

Feat. D. Vucicevic
20:59
Mary E. Money

Digoxin Update 2023: Are the Current Digoxin Monitoring Guidelines H…